2025. GLP-1 Receptor Agonist Repurposing Across Indications: Mechanism, Evidence and Trial Sequencing. Translational Medicine & Therapeutics Journal. 4, 1 (Feb. 2025), 10–18. DOI:https://doi.org/10.5281/zenodo.22649327.